Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal
{{output}}
Background: Immune-related hepatitis (IRH) occurs in 1 to 18% of immune checkpoint inhibitor (ICI)-treated patients. Steroids are usually recommended for grade≥3 IRH, but their impact on IRH resolution and patient survival remai... ...
